The BioInfect conference focuses on the issues surrounding the increasing threat of Antimicrobial Resistance and those addressing them. Michael Murray (Executive Chairman and CEO) shall be describing how MetalloBio is approaching these issues and how our innovation may be beneficial to creating long-lasting and comprehensive health outcomes. If you are going to BioInfect, please feel free to connect with Michael.